Participants with depression (ICD-10: F32/F33), all severity levels included.
Conditions
Interventions
Group 1: Intervention group with regular training via Neuronation MED and weekly psychoeducational materials by e-mail
The cognitive training will take place three times a week for 30 minutes over
a p
Sponsors
Universitätsklinikum Bonn
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: General requirements: - The patient is fluent in German. - The patient is able to use a smartphone with or without visual aids. - The patient is able to fully comprehend all verbal and written information provided and agrees to participate in the study. - The patient must provide a legally valid declaration of consent. Depression data: - The patient has received a clinically confirmed diagnosis of a depressive episode (F32) or recurrent depressive episode (F33) without psychotic symptoms, confirmed by means of the questionnaires specified above.
Exclusion criteria
Exclusion criteria: Health risks - Mental disorders: - Current or lifelong psychotic disorders (schizophrenia, schizotypal, delusional, schizoaffective, bipolar, cyclothymic disorders). - Life-threatening crisis or active suicidal tendencies (recorded in the MINI Dips). Health risks - Neurological diseases: - History of brain injury - Diseases of the central nervous system (CNS) - Epilepsy - Parkinson's disease - Huntington's disease - Multiple sclerosis - Stroke Health risks - other: - Infection with the human immunodeficiency virus (HIV) - Acquired immunodeficiency syndrome (AIDS) - recent infections/sepsis - concussion - head trauma - Benzodiazepine use - Illegal substance use including marijuana Medication: - Benzodiazepine medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Improvement in performance after the intervention in the areas of attention, language, memory, perception and executive functions, as assessed by neuropsychological examinations. - Reduction in scores on the depression scale (BDI-II) and current motivational ability (FAM). | — |
Secondary
| Measure | Time frame |
|---|---|
| - Improvement in everyday functioning, measured by changes in the scores in the WFIRS questionnaire. - Improvement in subjectively reported cognitive performance, measured by the scores in the SCI questionnaire. - Improvement in health-related quality of life, measured by the scores in the WHOQOL-BREF questionnaire. - Investigation of the relationship between individual variables, in particular between subjectively reported qualities and objectified cognitive performance. | — |
Countries
Germany
Contacts
Public ContactSilke Lux
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Bonn
Outcome results
None listed